Lvis
Payments companies reported to CMS as associated with Lvis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lvis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lvis
These are the largest totals companies reported as associated with Lvis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Copelan | Eden Prairie, MN | Neuroradiology | $1,317.17 |
| Omar Choudhri | Philadelphia, PA | Neurological Surgery | $419.50 |
| Henry Woo | Stony Brook, NY | Neurological Surgery | $377.76 |
| Eric Quach | Philadelphia, PA | Neurological Surgery | $377.76 |
| Sudeepta Dandapat | Milwaukee, WI | Neurology (Psychiatry & Neurology) | $234.46 |
| Thomas Wolfe | Milwaukee, WI | Neurology (Psychiatry & Neurology) | $234.46 |
| John Steele | Rochester Hills, MI | Neurological Surgery | $163.52 |
| Mohamad Orabi | Pontiac, MI | Neurology (Psychiatry & Neurology) | $163.52 |
| Byron Thompson | Ann Arbor, MI | Neurological Surgery | $163.52 |
| Anmar Razak | East Lansing, MI | Vascular Neurology | $163.52 |
Prescribed Lvis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.